Skip to:

NEWS

Jan 11 | Analyze cotton rat IFN-γ and Ferret IFN-γ with flow cytometry


Our specific IFN-γ antibodies to cotton rat IFN-γ and ferret IFN-γ are available conjugated to PF488P and PF647P fluorophores suitable for flow cytometry analysis.

View cotton rat IFN-γ Flow cytometry mAbs

View ferret IFN-γ Flow cytometry mAbs

...read more

Jan 2 | FluoroSpot detection reagent replacement


We have improved the detection reagents used in our FluoroSpot assays!

Epitope tag/anti-tag reagents are used as an amplification step in FluoroSpot assays. With our new tag/anti-tag reagents the detection of human and monkey IFN-γ is improved. As a consequence of this change, the detection reagents for IL-5, IL-17A and TNF-α in triple FluoroSpot kits have been updated.

Read more about the New reagents

...read more

"Mabtech service is highly customer-friendly and efficient. We have been using Mabtech ELISA kits for the past eight years with full satisfaction. Furthermore, I find Mabtech products the best for even developing my in-house ELISA."
Laksiri Gomes
Centre for Dengue Research
University of Sri Jayawardenepura
Sri Lanka
"Our research group uses Mabtech products for a variety of applications, especially investigating immunological responses in wildlife. We have been able to develop new assays for detecting diseases and feel that the quality of the products contributes to our research progress. The support from the Mabtech staff has been especially positive and we look forward to future collaborations."
Michele Miller
Division of Molecular Biology & Human Genetics
Faculty of Medicine and Health Sciences
Stellenbosch University
South Africa
"We have been using Mabtech antibodies in our ELISpot assays for several years with satisfaction. Recently we switched to the IFN/gamma/TNF-alpha Fluorospot assay in kit version and found it to consistently produce good quality results while effectively tripling our collection of functional data. The team at Mabtech assisted us during this transition, which resulted in a short optimisation and therefore minimal delay in continuing with our experiments. "
Jade Clarson
GVL and Immunotherapy
Cancer Theme
South Australian Health and Medical Research Institute (SAHMRI)
Australia